Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janet Pope

Showing results (81-90 of 167) with videos related to

Pageof 17
Sort By:
The Canadian Journal of Cardiology|October 4, 2011
Diagnosis, prevention, and management of statin adverse effects and intolerance: proceedings of a Canadian Working Group Consensus ConferenceG B John Mancini, Steven Baker, Jean Bergeron, et al.
Arthritis and Rheumatism|October 13, 2004
Randomized, double-blind, placebo-controlled glucosamine discontinuation trial in knee osteoarthritisJolanda Cibere, Jacek A Kopec, Anona Thorne, et al.
Journal of Clinical Epidemiology|March 22, 2006
A gradient of acute gastroenteritis was characterized, to assess risk of long-term health sequelae after drinking bacterial-contaminated waterAmit X Garg, John Marshall, Marina Salvadori, et al.
The Journal of Rheumatology|January 17, 2014
Antihomocitrullinated fibrinogen antibodies are specific to rheumatoid arthritis and frequently bind citrullinated proteins/peptidesMathias Scinocca, David A Bell, Maud Racapé, et al.
The Cochrane Database of Systematic Reviews|November 6, 2023
Phosphodiesterase 5 inhibitors (PDE5i) for the treatment of Raynaud's phenomenonNancy Maltez, Lara J Maxwell, Fadumo Rirash, et al.
The Journal of Rheumatology|March 3, 2016
How to Attract Trainees, a Pan-Canadian Perspective: Phase 1 of the "Training the Rheumatologists of Tomorrow" ProjectAlfred Cividino, Volodko Bakowsky, Susan Barr, et al.
Rheumatology and Therapy|May 25, 2023
Benefits of Autoantibody Enrichment in Early Rheumatoid Arthritis: Analysis of Efficacy Outcomes in Four Pooled Abatacept TrialsKaleb Michaud, Philip G Conaghan, Sang Hee Park, et al.
Rheumatology and Therapy|July 28, 2021
Prevalence of Renal Impairment in a US Commercially Insured Rheumatoid Arthritis Population: A Retrospective AnalysisJon T Giles, Lee S Simon, Janet Pope, et al.
The Journal of Rheumatology|May 5, 2007
Systemic sclerosis - continuing progress in developing clinical measures of responseDaniel Furst, Dinesh Khanna, Marco Matucci-Cerinic, et al.
Rheumatology and Therapy|January 20, 2023
Patient Disease Trajectories in Rheumatoid Arthritis Patients Treated with Baricitinib 4-mg in Four Phase 3 Clinical StudiesPeter C Taylor, Yun-Fei Chen, Janet Pope, et al.
Pageof 17

Showing results (81-90 of 167) with videos related to

Sort By:
Pageof 17
The Canadian Journal of Cardiology|October 4, 2011
Diagnosis, prevention, and management of statin adverse effects and intolerance: proceedings of a Canadian Working Group Consensus ConferenceG B John Mancini, Steven Baker, Jean Bergeron, et al.
Arthritis and Rheumatism|October 13, 2004
Randomized, double-blind, placebo-controlled glucosamine discontinuation trial in knee osteoarthritisJolanda Cibere, Jacek A Kopec, Anona Thorne, et al.
Journal of Clinical Epidemiology|March 22, 2006
A gradient of acute gastroenteritis was characterized, to assess risk of long-term health sequelae after drinking bacterial-contaminated waterAmit X Garg, John Marshall, Marina Salvadori, et al.
The Journal of Rheumatology|January 17, 2014
Antihomocitrullinated fibrinogen antibodies are specific to rheumatoid arthritis and frequently bind citrullinated proteins/peptidesMathias Scinocca, David A Bell, Maud Racapé, et al.
The Cochrane Database of Systematic Reviews|November 6, 2023
Phosphodiesterase 5 inhibitors (PDE5i) for the treatment of Raynaud's phenomenonNancy Maltez, Lara J Maxwell, Fadumo Rirash, et al.
The Journal of Rheumatology|March 3, 2016
How to Attract Trainees, a Pan-Canadian Perspective: Phase 1 of the "Training the Rheumatologists of Tomorrow" ProjectAlfred Cividino, Volodko Bakowsky, Susan Barr, et al.
Rheumatology and Therapy|May 25, 2023
Benefits of Autoantibody Enrichment in Early Rheumatoid Arthritis: Analysis of Efficacy Outcomes in Four Pooled Abatacept TrialsKaleb Michaud, Philip G Conaghan, Sang Hee Park, et al.
Rheumatology and Therapy|July 28, 2021
Prevalence of Renal Impairment in a US Commercially Insured Rheumatoid Arthritis Population: A Retrospective AnalysisJon T Giles, Lee S Simon, Janet Pope, et al.
The Journal of Rheumatology|May 5, 2007
Systemic sclerosis - continuing progress in developing clinical measures of responseDaniel Furst, Dinesh Khanna, Marco Matucci-Cerinic, et al.
Rheumatology and Therapy|January 20, 2023
Patient Disease Trajectories in Rheumatoid Arthritis Patients Treated with Baricitinib 4-mg in Four Phase 3 Clinical StudiesPeter C Taylor, Yun-Fei Chen, Janet Pope, et al.
Pageof 17